XML 11 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current assets    
Cash $ 694
Prepaid expenses and other current assets 11,858 25
Total Current Assets 12,552 25
Deferred offering costs 106,870
Marketable securities held in Trust Account 243,129,959
TOTAL ASSETS 243,142,511 106,895
Current liabilities    
Accrued expenses 1,286,872 1,000
Income taxes payable 39,765
Promissory note - related party 80,808
Total Current Liabilities 1,326,637 81,808
Advance from related party 353,994
Total Liabilities 1,680,631 81,808
Commitments and contingencies (see Note 7)
Common stock subject to possible redemption 23,507,001 shares at redemption value at December 31, 2020 236,461,872
Stockholders' Equity    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Common stock, $0.0001 par value; 50,000,000 shares authorized; 7,548,499 and 6,337,500 shares issued and outstanding (excluding 23,507,001 and no shares subject to possible redemption) at December 31, 2020 and 2019, respectively [1] 755 634
Additional paid-in capital 5,933,074 25,453
Accumulated deficit (933,821) (1,000)
Total Stockholders' Equity 5,000,008 25,087
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 243,142,511 $ 106,895
[1] As of December 31, 2019, included up to 787,500 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 6).